Insmed (INSM) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Insmed Revenue Highlights

Latest Revenue (Y)

$363.71M

Latest Revenue (Q)

$93.42M

Main Segment (Y)

Reportable Segment

Main Geography (Y)

UNITED STATES

Insmed Revenue by Period

Insmed Revenue by Year

Date	Revenue	Change
2024-12-31	$363.71M	19.17%
2023-12-31	$305.21M	24.39%
2022-12-31	$245.36M	30.19%
2021-12-31	$188.46M	14.63%
2020-12-31	$164.41M	20.48%
2019-12-31	$136.47M	1287.56%
2018-12-31	$9.84M	100.00%
2017-12-31	-	100.00%
2016-12-31	-	100.00%
2015-12-31	-	-100.00%
2014-12-31	$11.50M	-
2013-12-31	$11.50M	100.00%
2012-12-31	-	-100.00%
2011-12-31	$4.42M	-36.18%
2010-12-31	$6.92M	-33.28%
2009-12-31	$10.37M	-11.33%
2008-12-31	$11.70M	55.39%
2007-12-31	$7.53M	659.74%
2006-12-31	$991.00K	656.49%
2005-12-31	$131.00K	-4.38%
2004-12-31	$137.00K	-8.67%
2003-12-31	$150.00K	-92.33%
2002-12-31	$1.96M	560.47%
2001-12-31	$296.00K	393.33%
2000-12-31	$60.00K	-90.95%
1999-12-31	$663.16K	-

Insmed generated $363.71M in revenue during NA 2024, up 19.17% compared to the previous quarter, and up 266.52% compared to the same period a year ago.

Insmed Revenue by Quarter

Date	Revenue	Change
2024-09-30	$93.42M	3.41%
2024-06-30	$90.34M	19.66%
2024-03-31	$75.50M	-9.79%
2023-12-31	$83.69M	5.84%
2023-09-30	$79.07M	2.39%
2023-06-30	$77.23M	18.42%
2023-03-31	$65.21M	9.97%
2022-12-31	$59.30M	-12.45%
2022-09-30	$67.73M	3.85%
2022-06-30	$65.22M	22.81%
2022-03-31	$53.11M	-5.38%
2021-12-31	$56.12M	20.03%
2021-09-30	$46.76M	3.07%
2021-06-30	$45.37M	12.81%
2021-03-31	$40.21M	-2.90%
2020-12-31	$41.41M	-5.11%
2020-09-30	$43.64M	2.70%
2020-06-30	$42.49M	15.29%
2020-03-31	$36.86M	-19.36%
2019-12-31	$45.71M	17.55%
2019-09-30	$38.88M	29.74%
2019-06-30	$29.97M	36.85%
2019-03-31	$21.90M	122.69%
2018-12-31	$9.84M	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	100.00%
2017-12-31	-	100.00%
2017-09-30	-	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	-100.00%
2013-06-30	$11.50M	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	-100.00%
2011-12-31	$1.40M	222.53%
2011-09-30	$435.00K	-55.52%
2011-06-30	$978.00K	-38.91%
2011-03-31	$1.60M	21.20%
2010-12-31	$1.32M	-26.90%
2010-09-30	$1.81M	-3.06%
2010-06-30	$1.86M	-3.37%
2010-03-31	$1.93M	-22.47%
2009-12-31	$2.49M	0.53%
2009-09-30	$2.48M	-18.59%
2009-06-30	$3.04M	28.27%
2009-03-31	$2.37M	-17.10%
2008-12-31	$2.86M	-29.77%
2008-09-30	$4.07M	53.74%
2008-06-30	$2.65M	14.29%
2008-03-31	$2.32M	8.17%
2007-12-31	$2.14M	-

Insmed generated $93.42M in revenue during Q3 2024, up 3.41% compared to the previous quarter, and up 120.97% compared to the same period a year ago.

Insmed Revenue Breakdown

Insmed Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24
Reportable Segment	$363.71M

Insmed's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Insmed Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21
Europe And The Rest Of The World	$21.21M	$15.28M	$2.86M	$12.95M
UNITED STATES	$254.80M	$224.19M	$185.99M	$159.51M
JAPAN	$87.70M	$65.73M	$56.51M	$16.01M

Insmed's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (70.06%), JAPAN (24.11%), and Europe And The Rest Of The World (5.83%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Europe And The Rest Of The World	$11.37M	$5.57M	$4.26M	$4.48M	$3.84M	$3.97M	$2.99M	$-4.68M	$3.71M	$2.18M	$-1.31M
JAPAN	$51.83M	$20.98M	$14.89M	$20.95M	$16.03M	$15.59M	$13.16M	$15.50M	$14.48M	$15.85M	$10.68M
UNITED STATES	$131.58M	$66.87M	$56.35M	$58.26M	$59.20M	$57.66M	$49.07M	$48.48M	$49.54M	$47.19M	$3.53M

Insmed's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (67.55%), JAPAN (26.61%), and Europe And The Rest Of The World (5.84%).

Insmed Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BGNE	BeiGene	$2.46B	$929.17M
HALO	Halozyme Therapeutics	$1.02B	$290.08M
HRMY	Harmony Biosciences	$714.73M	$186.04M
APLS	Apellis Pharmaceuticals	$709.95M	$176.57M
RARE	Ultragenyx Pharmaceutical	$560.23M	$147.03M
BPMC	Blueprint Medicines	$508.82M	$128.18M
INSM	Insmed	$363.71M	$93.42M
ASND	Ascendis Pharma	$266.72M	$95.89M
SWTX	SpringWorks Therapeutics	$191.59M	$59.73M
DAWN	Day One Biopharmaceuticals	$131.16M	$20.07M
FENC	Fennec Pharmaceuticals	$47.54M	$6.97M
AGIO	Agios Pharmaceuticals	$36.50M	$8.96M
RNA	Avidity Biosciences	$10.90M	$2.04M
JANX	Janux Therapeutics	$10.59M	$8.90M
KROS	Keros Therapeutics	$3.55M	$37.00K
AKRO	Akero Therapeutics	-	-
RVMD	Revolution Medicines	-	-
EWTX	Edgewise Therapeutics	-	-

INSM Revenue FAQ

What is Insmed’s yearly revenue?

Insmed's yearly revenue for 2024 was $363.71M, representing an increase of 19.17% compared to 2023. The company's yearly revenue for 2023 was $305.21M, representing an increase of 24.39% compared to 2022. INSM's yearly revenue for 2022 was $245.36M, representing an increase of 30.19% compared to 2021.

What is Insmed’s quarterly revenue?

Insmed's quarterly revenue for Q3 2024 was $93.42M, a 3.41% increase from the previous quarter (Q2 2024), and a 18.15% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $90.34M, a 19.66% increase from the previous quarter (Q1 2024), and a 16.98% increase year-over-year (Q2 2023). INSM's quarterly revenue for Q1 2024 was $75.5M, a -9.79% decrease from the previous quarter (Q4 2023), and a 15.77% increase year-over-year (Q1 2023).

What is Insmed’s revenue growth rate?

Insmed's revenue growth rate for the last 3 years (2022-2024) was 48.24%, and for the last 5 years (2020-2024) was 121.22%.

What are Insmed’s revenue streams?

Insmed's revenue streams in c 24 are Reportable Segment

What is Insmed’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Insmed was Reportable Segment. This segment made a revenue of $363.71M, representing 100.00% of the company's total revenue.